Cancer and depression

Depression and Physical Illness

Volumn , Issue , 2006, Pages 211-237

  Simon, Alice E ^a   Palmer, Steven C ^a   Coyne, James C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926966771     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544293.011     Document Type: Chapter

References (151)

1. D. Stockton, T. Davies, N. Day, J. McCann, Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment. Br. Med. J.314(1997), 472–5.
2. C. S. McArdle, D. J. Hole, Outcome following surgery for colorectal cancer. Br. Med. Bull.64(2002), 119–25.
3. M. Coleman, P. Babb, P. Damiecki, et al., Cancer Survival Trends in England and Wales, 1971–1995(London: The Stationary Office, 1999).
4. American Cancer Society. Cancer Facts and Figures. (Atlanta, GA: American Cancer Society, 2005)
5. M. McMenamin, H. Barry, A. M. Lennon, et al., A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. Eur. J. Cancer41(2005), 393–7.
6. K. McCaffery, J. Wardle, J. Waller, Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev. Med.36(2003), 525–35.
7. D. Spiegel, J. Giese-Davis, Depression and cancer: mechanisms and disease progression. Biol. Psychiatry54(2003), 269–82.
8. W. F. Pirl, Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J. Natl. Cancer Inst. Monogr. (2004), 32–9.
9. M. J. Massie, Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr. (2004), 57–71.
10. J. C. Coyne, S. C. Palmer, P. J. Shapiro, R. Thompson, A. DeMichele, Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen. Hosp. Psychiatry26(2004), 121–8.
11. M. Harter, K. Reuter, A. Aschenbrenner, et al., Psychiatric disorders and associated factors in cancer: results of an interview studywith patients in inpatient, rehabilitation and outpatient treatment. Eur. J. Cancer37(2001), 1385–93.
12. D. W. Kissane, D. M. Clarke, J. Ikin, et al., Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med. J. Aust.169(1998), 192–6.
13. M. Sharpe, V. Strong, K. Allen, et al., Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br. J. Cancer90(2004), 314–20.
14. C. Burgess, V. Cornelius, S. Love, et al., Depression and anxiety in women with early breast cancer: five year observational cohort study. Br. Med. J.330(2005), 702.
15. M. Hotopf, J. Chidgey, J. J. Addington-Hall, K. L. Ly. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat. Med.16(2002), 81–97.
16. C. Classen, L. D. Butler, C. Koopman, et al., Supportive-expressive grouptherapy and distress in patientswith metastatic breast cancer: a randomized clinical intervention trial. Arch.Gen. Psychiatry58(2001), 494–501.
17. M. E. Lynch. The assessment and prevalence of affective disorders in advanced cancer. J. Palliat. Care11(1995), 10–18.
18. O. Evans, N. Singleton, H. Meltzer, R. Stewart, M. Prince. TheMentalHealth of Older People(London: The Stationery Office, 2003).
19. N. Singleton, R. Bumpstead, M. O’Brien, A. Lee, H. Meltzer Psychiatric Morbidity among Adults Living in Private Households 2000(London: The Stationery Office, 2001).
20. R. C. Kessler, P. Berglund, O. Demler, et al., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am.Med. Assoc.289(2003), 3095–105.
21. A. van’t Spijker, R. W. Trijsburg, H. J. Duivenvoorden, Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom. Med.59(1997), 280–93.
22. C. L. Raison, A. H. Miller, Depression in cancer: new developments regarding diagnosis and treatment. Biol. Psychiatry54(2003), 283–94.
23. D. Polsky, J. A. Doshi, S. Marcus, et al., Long-term risk for depressive symptoms after a medical diagnosis. Arch. Intern. Med.165(2005), 1260–66.
24. J. E. Barrett, J. A. Barrett, T. E. Oxman, P. D. Gerber, The prevalence of psychiatric disorders in a primary care practice. Arch. Gen. Psychiatry45(1988), 1100–106.
25. J. C. Coyne. Self-reported distress: analog or Ersatz depression? Psychol. Bull.116(1994), 29–45.
26. L. G. Kessler, P. D. Cleary, J. D. Burke, Jr, Psychiatric disorders in primary care. Results of a follow-up study. Arch. Gen. Psychiatry42(1985), 583–7.
27. H. C. Schulberg, M. McClelland, B. J. Burns, Depression and physical illness: the prevalence, causation and diagnosis of co-morbidity. Clin. Psychol. Rev.7(1987), 145–67.
28. W. Katon, The epidemiology of depression in medical care. Int. J. PsychiatryMed.17(1987), 93–112.
29. K. Reuter, M. Harter, The concepts of fatigue and depression in cancer. Eur. J. Cancer Care13(2004), 127–34.
30. J. C. Coyne, S. C. Palmer, P. A. Sullivan, Screening for depression in adults. Ann. Intern. Med.138(2003), 767–8.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (Washington, DC: American Psychiatric Association, 1994).
32. W. Katon, Depression: somatic symptoms and medical disorders in primary care. Compr. Psychiatry23(1982), 274–87.
33. S. Cavanaugh, D. C. Clark, R. D. Gibbons, Diagnosing depression in the hospitalized medically ill. Psychosomatics24(1983), 809–15.
34. D. A. Clark, A. Cook, D. Snow, Depressive symptomdifferences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J. Abnorm. Psychol.107(1998), 38–48.
35. D. C. Clark, C. S. vonAmmon, R. D. Gibbons, The core symptoms of depression in medical and psychiatric patients. J. Nerv. Ment. Dis.171(1983), 705–13.
36. S. A. Cohen-Cole, A. Stoudemire, Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr. Clin. North Am.10(1987), 1–17.
37. M. K. Popkin, A. L. Callies, E. A. Colon, A framework for the study of medical depression. Psychosomatics28(1987), 27–33.
38. P. C. Trask, Assessment of depression in cancer patients. J. Natl. Cancer Inst.Monogr. (2004), 80–92.
39. R. G. Kathol, A. Mutgi, J. Williams, G. Clamon, R. Noyes, Jr, Diagnosis of major depression in cancer patients according to four sets of criteria. Am. J. Psychiatry147(1990), 1021–4.
40. J. Endicott, Measurement of depression in patients with cancer. Cancer53(1984), 2243–9.
41. H. G. Koenig, L. K. George, B. L. Peterson, C. F. Pieper, Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am. J. Psychiatry154(1997), 1376–83.
42. J. C. Coyne, C. M. Pepper, H. Flynn, Significance of prior episodes of depression in two patient populations. J. Consult. Clin. Psychol.67(1999), 76–81.
43. H. G. Koenig, P. Pappas, T. Holsinger, J. R. Bachar, Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? J. Am. Geriatr. Soc.43(1995), 472–8.
44. K. Honda, R. D. Goodwin, Cancer and mental disorders in a national community sample: findings from the national comorbidity survey. Psychother. Psychosom.73(2004), 235–42.
45. J. C. Coyne, S. C. Palmer, National Comorbidity Survey data concerning cancer and depression lack credibility. Psychother. Psychosom.74(2005), 260–61.
46. J. Zabora, K. BrintzenhofeSzoc, B. Curbow, C. Hooker, The prevalence of psychological distress by cancer site. Psychooncology10(2001), 19–28.
47. M. Stommel, M. E. Kurtz, J. C. Kurtz, C. W. Given, B. A. Given, A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 23(2004), 564–73.
48. R. H. Osborne, G. R. Elsworth, J. L. Hopper, Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur. J. Cancer39(2003), 755–62.
49. J. Gallagher, M. Parle, D. Cairns, Appraisal and psychological distress six months after diagnosis of breast cancer. Br. J. Health Psychol.7(2002), 365–76.
50. K. Shimozuma, P. A. Ganz, L. Petersen, K. Hirji, Quality of life in the first year after breast cancer surgery rehabilitation needs and patterns of recovery. Breast Cancer Res. Treat.56(1999), 45–57.
51. D. W. Kissane, B. Grabsch, A. Love, et al., Psychiatric disorder inwomenwith early stage and advanced breast cancer a comparative analysis. Aust. N. Z. J. Psychiatry38(2004), 320–26.
52. E. M. Bleiker, F. Pouwer, H. M. van der Ploeg, J. W. Leer, H. J. Ader, Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient. Educ. Couns.40(2000), 209–17.
53. J. Norum, Adjuvant chemotherapy in Dukes’ B and C colorectal cancer has only a minor influence on psychological distress. Support. Care Cancer5(1997), 318–21.
54. J. C. Weeks, E. F. Cook, S. J. O’Day, et al., Relationship between cancer patients’ predictions of prognosis and their treatment preferences. J. Am. Med. Assoc.279(1998), 1709–14.
55. C. F. Quirt, W. J. Mackillop, A. D. Ginsburg, et al., Do doctors know when their patients don’t? A survey of doctor–patient communication in lung cancer. Lung Cancer18(1997), 1–20.
56. E. Chow, L. Andersson, R. Wong, et al., Patients with advanced cancer: a survey of the understanding of their illnessandexpectations frompalliative radiotherapy for symptomatic metastases. Clin. Oncol. (R. Coll. Radiol.)13(2001), 204–8.
57. M. Gattellari, P. N. Butow, M. H. Tattersall, S. M. Dunn, C. A. MacLeod, Misunderstanding in cancer patients: why shoot the messenger? Ann. Oncol.10(1999), 39–46.
58. L. Capuron, A. Ravaud, N. Gualde, et al., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology26(2001), 797–808.
59. D. L. Musselman, D. H. Lawson, J. F. Gumnick et al., Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med.344(2001), 961–6.
60. A. G. Paterson, P. C. Trask, L. I. Wagner, P. Esper, B. Redman, Validation of the FACT-BRM with interferon-alpha treated melanoma patients. Qual. Life Res.14(2005), 133–9.
61. B. Holzner, G. Kemmler, D. Cella, et al., Normative data for functional assessment of cancer therapy: general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol. 43(2004), 153–60.
62. C. S. Neitzert, P. Ritvo, J. Dancey, et al., The psychosocial impact of bone marrow transplantation a review of the literature. Bone Marrow Transplant. 22(1998), 409–22.
63. R. Illescas-Rico, F. Amaya-Ayala, J. L. Jimenez-Lopez, M. E. Caballero-Mendez, J. Gonzalez-Llaven, Increased incidence of anxiety and depression during bone marrowtransplantation. Arch. Med. Res.33(2002), 144–7.
64. R. K. Portenoy, H. T. Thaler, A. B. Kornblith, et al., Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res.3(1994), 183–9.
65. P. Hopwood, R. J. Stephens, Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J. Clin. Oncol.18(2000), 893–903.
66. B. Bennett, D. Goldstein, A. Lloyd, T. Davenport, I. Hickie, Fatigue and psychological distress: exploring the relationship in women treated for breast cancer. Eur. J. Cancer40(2004), 1689–95.
67. B. L. Andersen, Psychological interventions for cancer patients to enhance the quality of life. J. Consult Clin. Psychol.60(1992), 552–68.
68. E. Maunsell, J. Brisson, L. Deschenes, Psychological distress after initial treatment of breast cancer: assessment of potential risk factors. Cancer70(1992), 120–25.
69. A. J. Ramirez, M. A. Richards, S. R. Jarrett, I. S. Fentiman, Can mood disorder in women with breast cancer be identified preoperatively? Br. J. Cancer72(1995), 1509–12.
70. E. Maunsell, J. Brisson, L. Deschenes, N. Frasure-Smith, Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. J. Clin. Oncol.14(1996), 2747–55.
71. J. C. Coyne, R. Thompson, M. S. Klinkman, D. E. Nease, Jr, Emotional disorders in primary care. J. Consult. Clin. Psychol.70(2002), 798–809.
72. L. Fallowfield, D. Ratcliffe, V. Jenkins, J. Saul, Psychiatric morbidity and its recognition by doctors in patients with cancer. Br. J. Cancer84(2001), 1011–15.
73. S. D. Passik, W. Dugan, M. V. McDonald, et al., Oncologists’ recognition of depression in their patients with cancer. J. Clin. Oncol.16(1998), 1594–600.
74. M. V. McDonald, S. D. Passik, W. Dugan, et al., Nurses’ recognition of depression in their patients with cancer. Oncol. Nurs. Forum26(1999), 593–9.
75. B. M. Hoffman, M. A. Zevon, M. C. D’Arrigo, T. B. Cecchini, Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology13(2004), 792–9.
76. L. E. Carlson, B. D. Bultz, Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology13(2004), 837–49.
77. N. Akizuki, T. Akechi, T. Nakanishi, et al., Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer97(2003), 2605–13.
78. P. B. Jacobsen, K. A. Donovan, P. C. Trask, et al., Screening for psychologic distress in ambulatory cancer patients. Cancer103(2005), 1494–502.
79. L. S. Radloff, The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas.1(1977), 385–401.
80. L. R. Derogatis, N. Melisaratos, The Brief Symptom Inventory: an introductory report. Psychol. Med.13(1983), 595–605.
81. A. Zigmond, R. Snaith, The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand.67(1983), 361–70.
82. B. Lowe, K. Kroenke, K. Grafe, Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J. Psychosom. Res.58(2005), 163–71.
83. B. Lowe, J. Unutzer, C. M. Callahan, A. J. Perkins, K. Kroenke, Monitoring depression treatment outcomes with the patient health questionnaire-9. Med. Care42(2004), 1194–201.
84. V. Henkel, R. Mergl, J. C. Coyne, et al., Screening for depression in primary care: will one or two items suffice? Eur. Arch. Psychiatry Clin. Neurosci.254(2004), 215–23.
85. R. L. Spitzer, J. B. Williams, K. Kroenke, et al., Utility of a new procedure for diagnosing mental disorders in primary care: thePRIME-MD1000 study. J. Am.Med.Assoc.272(1994), 1749–56.
86. A. C. Leon, J. E. Kelsey, A. Pleil, et al., An evaluation of a computer assisted telephone interview for screening for mental disorders among primary care patients. J. Nerv. Ment. Dis.187(1999), 308–11.
87. S. Fechner-Bates, J. C. Coyne, T. L. Schwenk, The relationship of self-reported distress to depressive disorders and other psychopathology. J. Consult. Clin. Psychol.62(1994), 550–9.
88. K. Shimizu, T. Akechi, M. Okamura, et al., Usefulness of the nurse-assisted screening and psychiatric referral program. Cancer103(2005), 1949–56.
89. S. A. McLachlan, A. Allenby, J. Matthews, et al., Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J. Clin. Oncol.19(2001), 4117–25.
90. S. C. Palmer, J. C. Coyne, Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J. Psychosom. Res.54(2003), 279–87.
91. A. J. Roth, A. B. Kornblith, L. Batel-Copel, et al., Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer82(1998), 1904–8.
92. P. Maguire, Improving communication with cancer patients. Eur. J. Cancer35(1999), 1415–22.
93. C. Dean, Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J. Psychosom. Res.31(1987), 385–92.
94. J. Harrison, P. Maguire, Predictors of psychiatric morbidity in cancer patients. Br. J. Psychiatry165(1994), 593–8.
95. J. S. McDaniel, D. L. Musselman, C. B. Nemerof, Cancer and depression: Theory and treatment. Psychiatr. Ann.27(1997), 360–64.
96. D. L. Evans, D. S. Charney, L. Lewis, et al., Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiaty58(2005), 175–89.
97. D. Razavi, J. F. Allilaire, M. Smith, et al., The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr. Scand.94(1996), 205–10.
98. A. K. Koike, J. Unutzer, K. B. Wells, Improving the care for depression in patients with comorbid medical illness. Am. J. Psychiatry159(2002), 1738–45.
99. T. Sheard, P. Maguire, The effect of psychological interventions on anxiety and depression in cancer patients results of two meta-analyses. Br. J. Cancer80(1999), 1770–80.
100. A. M. Nezu, C. M. Nezu, S. H. Felgoise, K. S. McClure, P. S. Houts, Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J. Consult. Clin. Psychol.71(2003), 1036–48.
101. M. J. Fisch, P. J. Loehrer, J. Kristeller, et al., Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of theHoosier OncologyGroup. J. Clin. Oncol.21(2003), 1937–43.
102. J. C. Coyne, S. C. Palmer, P. J. Shapiro, Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified. J. Clin. Oncol.22(2004), 205–6.
103. B. A. Erwin, P. A. Sullivan, T. R. ten Have, Trial of antidepressants for mildly depressed cancer patients should have been reported in a manner allowing independent evaluation of investigators’ claims. J. Clin. Oncol.22(2004), 753–4.
104. C. Moynihan, J. M. Bliss, J. Davidson, L. Burchell, A. Horwich, Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial. Br. Med. J.316(1998), 429–35.
105. M. Sharpe, V. Strong, K. Allen, et al., Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nursedelivered intervention. Br. J. Cancer90(2004), 310–13.
106. W. Sollner, S. Maislinger, A. Konig, A. Devries, P. Lukas, Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psychooncology. 13(2004), 893–7.
107. P. J. Shapiro, J. C. Coyne, L. K. Kruus, et al., Interest in services among prostate cancer patients receiving androgen deprivation therapy. Psychooncology13(2004), 512–25.
108. E. G. Eakin, L. A. Strycker, Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives. Psychooncology10(2001), 103–13.
109. J. C. Holland, History of psycho-oncology overcoming attitudinal and conceptual barriers. Psychosom. Med.64(2002), 206–21.
110. M. Beutel, G. Henrich, A. Sellschopp, M. Keller, W. Adermayer, Needs and utilization of ambulatory psychosocial services by cancer patients – exemplified by the oncologic day clinic. Psychother. Psychosom. Med. Psychol.46(1996), 304–11.
111. R. E. Gray, M. Fitch, C. Davis, C. Phillips, Interviews with men with prostate cancer about their self-help group experience. J. Palliat. Care13(1997), 15–21.
112. K. N. Moore, A. Estey, The early post-operative concerns of men after radical prostatectomy. J. Adv. Nurs.29(1999), 1121–9.
113. F. Wong, D. E. Stewart, J. Dancey, et al., Menwith prostate cancer: influence of psychological factors on informational needs and decision making. J. Psychosom. Res.49(2000), 13–9.
114. P. J. Goodwin, M. Leszcz, G. Quirt, et al., Lessons learned from enrollment in the BEST study: a multicenter, randomized trial of group psychosocial support in metastatic breast cancer. J. Clin. Epidemiol.53(2000), 47–55.
115. D. A. Regier, W. E. Narrow, D. S. Rae, et al., The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry50(1993), 85–94.
116. P. A. Sullivan, J. C. Coyne, S. C. Palmer, J. M. Metz, Antidepressant use in breast cancer patients: an Oncolink study. Presented at the 27th annual meeting of the American Society of Preventive Oncology, Philadelphia, PA, 3 March 2003.
117. W. J. Katon, J. Unutzer, G. Simon, Treatment of depression in primary care: where we are, where we can go. Med. Care42(2004), 1153–7.
118. J. W. Williams, Jr, C. D. Mulrow, E. Chiquette, et al., A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann. Intern. Med.132(2000), 743–56.
119. W. Katon, K. M. Von, E. Lin, et al., Collaborative management to achieve treatment guidelines: impact on depression in primary care. J. Am. Med. Assoc.273(1995), 1026–31.
120. J. C. Coyne, S. C. Palmer, P. A. Sullivan, Is case-finding an inefficient way of addressing depression as a public health problem? Pharmacoepidemiol. Drug Saf.11(2002), 545–7.
121. D. S. Brody, Improving the management of depression in primary care: recent accomplishments and ongoing challenges. Dis. Manage Health Outcomes11(2003), 21–31.
122. T. E. Oxman, A. J. Dietrich, H. C. Schulberg, The depression care manager and mental health specialist as collaborators within primary care. Am. J. Geriatr. Psychiatry11(2003), 507–16.
123. H. C. Schulberg, C. Bryce, K. Chism, et al., Managing late-life depression in primary care practice: a case study of the health specialist’s role. Int. J. Geriatr. Psychiatry16(2001), 577–84.
124. E. M. Hunkeler, J. F. Meresman, W. A. Hargreaves, et al., Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch. Fam. Med.9(2000), 700–708.
125. G. E. Simon, M. VonKorff, C. Rutter, E. Wagner, Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. Br. Med. J.320(2000), 550–54.
126. V. Strong, M. Sharpe, A. Cull, et al., Can oncology nurses treat depression? A pilot project. J. Adv. Nurs.46(2004), 542–8.
127. M. Dwight-Johnson, K. Ell, P. J. Lee, Can collaborative care address the needs of lowincome Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosomatics46(2005), 224–32.
128. J. Lemon, S. Edelman, Perceptions of the ‘mind-cancer’ relationship among the public, cancer patients, and oncologists. J. Psychosoc. Oncol.21(2004), 43–58.
129. B. D. Doan, R. E. Gray, C. S. Davis, Belief in psychological effects on cancer. Psychooncology2(1993), 139–50.
130. B. L. Andersen, W. B. Farrar, D. M. Golden-Kreutz, et al., Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol.22(2004), 3570–80.
131. H. Faller, M. Schmidt, Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology13(2004), 359–63.
132. F. Efficace, L. Biganzoli, M. Piccart, et al., Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur. J. Cancer40(2004), 1021–30.
133. P. J. Goodwin, M. Leszcz, M. Ennis, et al., The effect of group psychosocial support on survival in metastatic breast cancer. N. Engl. J. Med.345(2001), 1719–26.
134. F. Efficace, P. Therasse, M. J. Piccart, et al., Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population an internationalmulticenter study. J. Clin. Oncol.22(2004), 3381–8.
135. B. Garssen, Psychological factorsandcancer development: evidence after30yearsof research. Clin. Psychol. Rev.24(2004), 315–38.
136. S. Greer, T. Morris, K. W. Pettingale, Psychological response to breast cancer: effect on outcome. Lancet2(1979), 785–7.
137. M. Watson, J. S. Haviland, S. Greer, J. Davidson, J. M. Bliss, Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet354(1999), 1331–6.
138. M. Watson, J. Homewood, J. Haviland, J. M. Bliss, Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur. J. Cancer41(2005), 1665–6.
139. D. Spiegel, J. R. Bloom, H. C. Kraemer, E. Gottheil, Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet2(1989), 888–91.
140. D. Spiegel, Effects of psychotherapy on cancer survival. Nat. Rev. Cancer2(2002), 383–9.
141. F. I. Fawzy, N. W. Fawzy, C. S. Hyun, et al., Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatry50(1993), 681–9.
142. J. L. Richardson, D. R. Shelton, M. Krailo, A. M. Levine, The effect of compliance with treatment on survival among patients with hematologic malignancies. J. Clin. Oncol.8(1990), 356–64.
143. T. Kuchler, D. Henne-Bruns, S. Rappat, et al., Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology46(1999), 322–35.
144. R. McCorkle, N. E. Strumpf, I. F. Nuamah, et al., A specialized home care intervention improves survival among older post-surgical cancer patients. J. Am. Geriatr. Soc.48(2000), 1707–13.
145. M. W. Linn, B. S. Linn, R. Harris, Effects of counseling for late stage cancer patients. Cancer49(1982), 1048–55.
146. A. Ilnyckyj, J. Farber, M. Cheang, B. Weinerman, A randomized controlled trial of psychotherapeutic intervention in cancer patients.Ann. R. Coll. Physicians Surg. Can. 27(1994), 93–6.
147. A. J. Cunningham, C. V. Edmonds, G. P. Jenkins, et al., A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology7(1998), 508–17.
148. S. Edelman, J. Lemon, D. R. Bell, A. D. Kidman, Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology8(1999), 474–81.
149. S. C. Palmer, J. C. Coyne, Examining the evidence that psychotherapy improves the survival of cancer patients. Biol. Psychiatry56(2004), 61–2.
150. N. Frasure-Smith, F. Lesperance, Reflections on depression as a cardiac risk factor. Psychosom. Med. 67: Suppl 1 (2005), 19–25.
151. F. Lesperance, N. Frasure-Smith, The seduction of death. Psychosom.Med.61(1999), 18–20.